pinacolyl methylphosphonic acid has been researched along with Disease Models, Animal in 1 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, SR; Bzdega, T; Der, EK; Farago, PR; Hark, TJ; Janczura, KJ; Lavin, KM; Lee, JC; Lee, MJ; Madore, JC; Neale, JH; Olszewski, RT; Profaci, CP | 1 |
1 other study(ies) available for pinacolyl methylphosphonic acid and Disease Models, Animal
| Article | Year |
|---|---|
NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Exploratory Behavior; Glutamate Carboxypeptidase II; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Recognition, Psychology; Risperidone; Schizophrenia; Soman; Urea | 2012 |